Industrial-metal outfit Godflesh announced an abrupt end to live performances after frontman Justin Broadrick underwent major abdominal surgery and was medically advised to stop shouting. The band will complete two near-finished records, but Broadrick’s recovery imposes limits that make touring and the group’s traditional stage approach unsafe.
Broadrick revealed the decision on Instagram, describing a repair for a serious inguinal hernia that required an open operation rather than a minimally invasive procedure. Surgeons warned that vigorous vocal projection and the physical strain of Godflesh’s live sets could trigger further hernias or a catastrophic weakening of his abdominal wall.
Immediate consequences and what’s already recorded
The band says live performances have effectively ended from the date of the surgery. Work on two studio albums that were already in progress will continue, with one—titled Decay—already tracked and awaiting mixing. The band plans to release that record through Relapse Records later this summer, pending final production steps.
The other album, described as the group’s last full-length LP, was written almost a year and a half ago and is slated for recording toward the end of this year. After those releases, Broadrick has indicated there will be no further Godflesh studio albums or live shows, though the archives could still yield occasional live or dub releases.
What this means for Broadrick’s other projects
Broadrick is not leaving music. He confirmed he can continue performing with projects that do not demand shouted vocals or strenuous stage activity—specifically naming Jesu and JK Flesh. He also plans a new solo effort that will explore abrasive sonic textures using guitars and electronics, but explicitly without the forceful vocal style associated with Godflesh.
- Surgery details: Open repair for a substantial inguinal hernia; surgeon cautioned against shouting and heavy abdominal strain.
- Live shows: Ceased immediately following surgery; recent European appearances now appear to be the band’s final live dates.
- Albums: Decay recorded and pending mixing; planned release late summer on Relapse Records. Final LP written and scheduled for end-of-year recording.
- Future releases: No new studio albums or concerts planned after the two in progress; potential archival or remix releases still possible.
- Broadrick’s next steps: Continue with Jesu and JK Flesh; start a new solo project focused on heavy electronic and guitar work without shouted vocals.
Godflesh’s decision draws a line under a four-decade run that began in Birmingham in 1988, when Justin Broadrick and B.C. Green formed the group. Across nine studio albums to date—and a lasting influence on industrial and extreme music—the band helped define a harsh, mechanical sound that other artists have repeatedly cited as formative.
The announcement carries immediate implications for fans, promoters and festivals: with live activity halted, any planned appearances or tours will need to be cancelled or reconfigured. For listeners, the closing chapter will arrive on record rather than onstage: two final albums are set to document the band’s last creative phase.
Broadrick framed the change as a medical necessity rather than a creative end. While Godflesh’s era of live confrontational performance appears finished, the frontman’s continued involvement in other projects suggests his artistic voice will remain active—if now channeled in less physically demanding forms.
Similar Posts
- Iceage ends five-year silence with surprise new single
- Jay-Z returns to Yankee Stadium for two nights honoring Reasonable Doubt, The Blueprint
- Phil Campbell, Motörhead axeman, dies: fans mourn rock legend at 64
- Broken Social Scene unveils new single Hey Amanda: stream it today
- Drummer from 2000s rock band exits: shares bittersweet reasons for leaving
Hello, I’m Atlas. I explore the latest musical releases for you and guide you to your next sonic favorites.